Business
Neurotech to treat autism, epilepsy and ADHD using Dolce Cann’s proprietary cannabis strains – Small Caps
Neurotech International (ASX: NTI) has collared an exclusive global licence to use Dolce Cann Global’s cannabis strains to treat autism, epilepsy and ADHD.
Neurotech International (ASX: NTI) has collared an exclusive global licence to use Dolce Cann Globals cannabis strains to treat autism, epilepsy and ADHD.
Dolce is an Australian based medicinal cann…
Continue Reading